Loyal is a clinical-trial network site in San Francisco, United States that is actively enrolling for the canine longevity pill.
“Sponsor of LOY-002. Runs the clinical partner network for early access.”
Loyal is a clinical-trial network site serving San Francisco, North America, United States. is presently enrolling eligible patients into an early-access programme for the canine longevity drug, with intake handled by their internal medicine team.
We surfaced this provider after picking up the following signal during our scan: "Sponsor of LOY-002. Runs the clinical partner network for early access.…"
Even before the pill itself rolls out widely, owners use Loyal for follow-up labs, study coordinator support, trial screening, all of which contribute to the kind of senior-dog baseline we recommend establishing in advance of any new longevity protocol. If you live in or near San Francisco, North America, United States, having a relationship with a practice like this in place — bloodwork on file, a known body-condition score, a current vaccine record — is what keeps the door open the moment a new treatment is offered locally.
When you call Loyal, the most useful questions are simple ones: do they have a waitlist for canine longevity treatment, what does their senior-wellness baseline visit include, and are they participating in any ongoing geroscience or longevity trials. Practices in United States appreciate owners who arrive prepared, and the answers help us update this page for future readers.
We update this entry whenever the provider's status changes, whenever new coverage is published about their longevity programme, or whenever an owner submits a correction. If you've recently visited Loyal and can confirm what they are or aren't doing today, the contact form at the bottom of this page is the fastest way to keep this entry honest.
- ›clinical trial enrollment
- ›screening
- ›study coordinator support
Service list is what we expect for a clinical-trial network of this kind. Confirm specifics with the practice directly.
- 1.Are you participating in any canine longevity drug programs (early-access, trials, or waitlists)?
- 2.What is your typical senior-dog wellness baseline visit — bloodwork, body-condition, cognitive screen?
- 3.If the canine longevity pill is approved in United States, would my dog need to be an existing patient first?
- 4.Do you keep a notification list for owners interested in new longevity treatments?
- 5.What records would you want me to bring on a first visit?
Free, forever, and ad-free.
- Canine Longevity Atlas · 5/4/2026Pre-launch dossier: what we know about the canine longevity pill in 2026
An owner-friendly briefing on every public data point worth tracking before the first true canine longevity drug clears its final regulatory hurdles.
- Biotech Tracker · 5/2/2026Loyal-style biotech valuations climb on Phase 2 readouts
Private valuations of veterinary geroscience companies have climbed sharply on the back of two recent positive Phase 2 readouts, with one late-stage funding round closing at more than triple the company's previous valuation.
- Google News · 3/5/2026Exploring the Quest for Extended Canine Lifespan: The New Age of Dog Longevity Research
With recent advancements in biotechnology, researchers are vigorously exploring ways to slow down the aging process in dogs, aiming for the ambitious goal of significantly extending their lifespan. A fresh wave of interest in geroscience and novel compounds inspired by existing research is fueling this exciting frontier, promising a future where our furry companions could enjoy more vibrant years alongside us.
- Google News · 2/11/2026Loyal Secures $100 Million in Series C Funding to Propel Canine Longevity Research
In a significant step forward for canine health, Loyal has successfully raised $100 million in a Series C funding round, spearheaded by age1. This investment aims to advance the development of the first-ever longevity drug for dogs, which draws inspiration from emerging research in geroscience and senolytics.
- Google News · 2/11/2026Loyal Secures $100M Series C Funding to Propel First Longevity Drug for Dogs
Loyal, an innovative company at the forefront of canine health, has successfully raised $100 million in a Series C funding round led by age1. This significant investment aims to advance their groundbreaking research into the first longevity drug designed specifically for dogs, marking a pivotal moment in veterinary science.
- Google News · 2/11/2026Loyal Secures $100 Million as Canine Longevity Pill Approaches Approval
Loyal, a promising player in the field of veterinary longevity, has successfully raised $100 million to support the development of its groundbreaking dog longevity drug, which is on the verge of regulatory approval. This funding milestone highlights the growing interest in the potential of geroscience to enhance the lives of our canine companions.
What this provider can offer is partly limited by what regulators in United States have approved. We track every status change.
Read the full United States brief →- Loyal — clinical partner network (USA)Loyal — clinical partner network (USA) is a clinical-trial network site in across multiple regions that is actively enrolling for the canine longevity pill.
- Cellular Longevity early-access vetsCellular Longevity early-access vets is a clinical-trial network site in across multiple regions that is running an interest list for the canine longevity pill.
- Cellular Longevity Early-Access NetworkCellular Longevity Early-Access Network is a clinical-trial network site in across multiple regions that is running an interest list for the canine longevity pill.
- VCA Animal Hospitals — selected California sitesLos AngelesVCA Animal Hospitals — selected California sites is a general veterinary practice in Los Angeles that is preparing to offer the canine longevity pill.
- VCA Animal HospitalsLos AngelesVCA Animal Hospitals is a general veterinary practice in Los Angeles that is preparing to offer the canine longevity pill.
- Mars Veterinary HealthMars Veterinary Health is a general veterinary practice in across multiple regions that is preparing to offer the canine longevity pill.
Tell us what’s changed: a new program, a closed waitlist, a corrected phone number, an updated status. We update this page as soon as we can verify.